INTRODUCTION: In clinical settings, neuropsychological test performance is traditionally evaluated with total summary scores (TSS). However, recent studies demonstrated that indices of intraindividual variability (IIV) yielded unique information complementing TSS. This 18-month longitudinal study sought to determine whether IIV indices derived from a multitrial list-learning test (the Rey Auditory Verbal Learning Test) provided incremental utility in predicting cognitive decline in older adults compared to TSS. METHOD: Ninety-nine cognitively intact older adults (aged 65 to 89 years) underwent neuropsychological testing (including the Rey Auditory Verbal Learning Test) at baseline and 18-month follow-up. Participants were classified as cognitively stable (n = 65) or declining (n = 34) based on changes in their neuropsychological test performance. Logistic regression modeling tested the ability of baseline TSS indices (sum of Trials 1-5, immediate recall, and delayed recall) and IIV indices (lost access and gained access) to discriminate between stable and declining individuals. RESULTS: Higher values of both lost access and gained access at baseline were associated with an increased risk for decline at 18-month follow-up. Further, the IIV indices provided predictive utility above and beyond the TSS indices. CONCLUSION: These results highlight the value of analyzing IIV in addition to TSS during neuropsychological evaluation in older adults. High levels of IIV may reflect impairment in anterograde memory systems and/or executive dysfunction that may serve as a prognostic indicator of cognitive decline.
INTRODUCTION: In clinical settings, neuropsychological test performance is traditionally evaluated with total summary scores (TSS). However, recent studies demonstrated that indices of intraindividual variability (IIV) yielded unique information complementing TSS. This 18-month longitudinal study sought to determine whether IIV indices derived from a multitrial list-learning test (the Rey Auditory Verbal Learning Test) provided incremental utility in predicting cognitive decline in older adults compared to TSS. METHOD: Ninety-nine cognitively intact older adults (aged 65 to 89 years) underwent neuropsychological testing (including the Rey Auditory Verbal Learning Test) at baseline and 18-month follow-up. Participants were classified as cognitively stable (n = 65) or declining (n = 34) based on changes in their neuropsychological test performance. Logistic regression modeling tested the ability of baseline TSS indices (sum of Trials 1-5, immediate recall, and delayed recall) and IIV indices (lost access and gained access) to discriminate between stable and declining individuals. RESULTS: Higher values of both lost access and gained access at baseline were associated with an increased risk for decline at 18-month follow-up. Further, the IIV indices provided predictive utility above and beyond the TSS indices. CONCLUSION: These results highlight the value of analyzing IIV in addition to TSS during neuropsychological evaluation in older adults. High levels of IIV may reflect impairment in anterograde memory systems and/or executive dysfunction that may serve as a prognostic indicator of cognitive decline.
Authors: John L Woodard; Michael A Sugarman; Kristy A Nielson; J Carson Smith; Michael Seidenberg; Sally Durgerian; Alissa Butts; Nathan Hantke; Melissa Lancaster; Monica A Matthews; Stephen M Rao Journal: Curr Alzheimer Res Date: 2012-05 Impact factor: 3.498
Authors: Alyssa A Gamaldo; Yang An; Jason C Allaire; Melissa H Kitner-Triolo; Alan B Zonderman Journal: Neuropsychology Date: 2012-07 Impact factor: 3.295
Authors: Nathan Hantke; Kristy A Nielson; John L Woodard; Leslie M Guidotti Breting; Alissa Butts; Michael Seidenberg; J Carson Smith; Sally Durgerian; Melissa Lancaster; Monica Matthews; Michael A Sugarman; Stephen M Rao Journal: J Int Neuropsychol Soc Date: 2012-11-30 Impact factor: 2.892
Authors: Christina D Kay; Michael Seidenberg; Sally Durgerian; Kristy A Nielson; J Carson Smith; John L Woodard; Stephen M Rao Journal: J Clin Exp Neuropsychol Date: 2017-01-04 Impact factor: 2.475